Liver transplantation is linked to durable survival for patients with neuroendocrine liver metastases, but careful patient ...
Zocilurtatug pelitecan has shown clinically meaningful responses and manageable safety in heavily pretreated patients with ...
First-line treatment duration may be a clinically useful predictor for 177Lu-DOTATATE retreatment patient selection, ...
According to data from the SwissNET registry of patients with GI-NETS, response to [177Lu]Lu-edotreotide is not influenced by ...
Patients with NETS who have lower physical activity levels have greater fatigue and worse quality of life than those who are more physically active.
NETest2.0 accurately identified active NET disease and provided clinically meaningful longitudinal surveillance information.
Cabozantinib improves PFS over placebo in patients with functional or nonfunctional extrapancreatic or pancreatic ...
Nearly 20% of patients with M0 pancreatic neuroendocrine tumors (pNETS) go on to develop metastases within 4 years after ...
The new ASTRO guideline is based on a systematic review of evidence and expert opinion and includes recommendations for MHF, ...
A sustained OS improvement is seen in patients with metastatic or recurrent cervical cancer who receive atezolizumab plus bevacizumab and chemo.
For patients with colorectal liver metastases (CRLM), laparoscopic liver resection (LLR) is associated with lower postoperative morbidity than open liver resection (OLR), with similar long-term ...
Active surveillance has similar 5-year OS as standard surgery in esophageal cancer patients who have a CCR after neoadjuvant chemoradiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results